Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.12−0.13 (-1.79%)
Close on Nov 16, 2026Market cap $427.95MP/E –Yield –
Orchestra BioMed cash
Cash and short-term investments held at the end of each period.
Orchestra BioMed's cash was $109.96M at Jun 30, 2026. For fiscal 2025 it was $106.51M, up 59.4% from the year before. The highest annual figure on record is $106.51M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.51M | +59.4% |
| FY2024 | Dec 31, 2024 | $66.81M | -23.7% |
| FY2023 | Dec 31, 2023 | $87.53M | +4.6% |
| FY2022 | Dec 31, 2022 | $83.70M | +742.2% |
| FY2021 | Dec 31, 2021 | $9.94M | +390.3% |
| FY2020 | Dec 31, 2020 | $2.03M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $109.96M | +224.1% |
| Q1 FY2026 | Mar 31, 2026 | $94.40M | +89.2% |
| Q4 FY2025 | Dec 31, 2025 | $106.51M | +59.4% |
| Q3 FY2025 | Sep 30, 2025 | $95.82M | +43.2% |
| Q2 FY2025 | Jun 30, 2025 | $33.92M | -48.0% |
| Q1 FY2025 | Mar 31, 2025 | $49.88M | -33.5% |
| Q4 FY2024 | Dec 31, 2024 | $66.81M | -23.7% |
| Q3 FY2024 | Sep 30, 2024 | $66.93M | -38.3% |
| Q2 FY2024 | Jun 30, 2024 | $65.18M | -44.6% |
| Q1 FY2024 | Mar 31, 2024 | $75.02M | -41.0% |
| Q4 FY2023 | Dec 31, 2023 | $87.53M | +4.6% |
| Q3 FY2023 | Sep 30, 2023 | $108.49M | +11.8% |
| Q2 FY2023 | Jun 30, 2023 | $117.70M | +10.0% |
| Q1 FY2023 | Mar 31, 2023 | $127.13M | +333.4% |
| Q4 FY2022 | Dec 31, 2022 | $83.70M | +742.2% |
| Q3 FY2022 | Sep 30, 2022 | $97.00M | +5339.1% |
| Q2 FY2022 | Jun 30, 2022 | $106.97M | +5496.9% |
| Q1 FY2022 | Mar 31, 2022 | $29.33M | +1403.8% |
| Q4 FY2021 | Dec 31, 2021 | $9.94M | +390.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.78M | -12.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.91M | +886.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.95M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.03M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.04M | – |
| Q2 FY2020 | Jun 30, 2020 | $193.69K | – |
See a number that looks wrong?